Medical Condition News

RSS

Global action on reducing mercury emissions should lead to billions in economic benefits for U.S.

Mercury pollution is a global problem with local consequences: Emissions from coal-fired power plants and other sources travel around the world through the atmosphere, eventually settling in oceans and waterways, where the pollutant gradually accumulates in fish. Consumption of mercury-contaminated seafood leads to increased risk for cardiovascular disease and cognitive impairments.

6 Jan 2016

Easy-to-follow MIND diet helps lower Alzheimer's risk

A diet created, studied and reported on by researchers at Rush University Medical Center has been ranked the easiest diet to follow and the second best overall diet (tying in both categories) for 2016 by U.S. News & World Report.

6 Jan 2016

Genetic mutation in starlings could shed light on mitochondrial disease in humans

Deakin University and UNSW Australia researchers have made a rare observation of rapid evolution in action in the wild, documenting the spread of a newly arisen genetic mutation in invasive starlings, which could shed light on mitochondrial disease in humans.

6 Jan 2016

Study shows clear role of bacteria in modulating immune function in the lungs

Microbiota--the trillions of bacteria that co-exist in the body--regulate the ability of lung dendritic cells to generate immune responses, according to a study led by researchers from the Icahn School of Medicine at Mount Sinai, published online in the Journal of Experimental Medicine.

6 Jan 2016

Local health departments could play vital role in tackling mental health issues in U.S.

Local health departments could play a significant role in tackling mental health issues in the United States, according to a recent study conducted by faculty in Drexel's Dornsife School of Public Health.

6 Jan 2016

New research looks at heavy users of mental health care

While a small number of people account for a disproportionately large portion of health services use, heavy users of mental health care have substantially different patterns of health care use than other heavy users of health care, according to new research by the Centre for Addiction and Mental Health and the Institute for Clinical Evaluative Sciences.

6 Jan 2016

CAMH researchers identify 428 distinct disease conditions that co-occur in people with FASD

Researchers at the Centre for Addiction and Mental Health have identified 428 distinct disease conditions that co-occur in people with Fetal Alcohol Spectrum Disorders (FASD), in the most comprehensive review of its kind.

6 Jan 2016

Radiation therapy lowers risk of cancer recurrence in pancreatic cancer surgery patients

Radiation therapy was associated with a lower risk of cancer recurrence in pancreatic cancer surgery patients, making it, like chemotherapy, an important addition to treatment, Mayo Clinic research found.

6 Jan 2016

Alpha-synuclein protein involved in Parkinson's disease pathology does not behave like a 'prion'

In Parkinson's disease, the protein "alpha-synuclein" aggregates within neurons of patients and appears to propagate across interconnected areas of the brain. How this happens remains largely unknown.

6 Jan 2016

Vision of Britain report shows more than 3 in 10 GPs ‘de-skilled’ in diagnosing eye conditions

New research released today reveals an alarming, self-acknowledged gap in family doctors’ skills when it comes to diagnosing and treating patient’s eye conditions.

6 Jan 2016

Women who earn less than male counterparts more likely to experience depression, anxiety

The odds of major depressive disorder and generalized anxiety disorder were markedly greater among women who earned less than their male counterparts, with whom they were matched on education and years of experience, according to new research conducted at Columbia University's Mailman School of Public Health.

6 Jan 2016

Study findings question validity of some genetic variations linked with cardiac disorders

A review of medical records of patients with genetic variations linked with cardiac disorders found that patients often did not have any symptoms or signs of the conditions, questioning the validity of some genetic variations thought to be related to serious disorders, according to a study in the January 5 issue of JAMA.

6 Jan 2016

Diet or aerobic exercise improves ability to exercise for obese older patients with heart failure

Among obese older patients with a common type of heart failure, calorie restriction or aerobic exercise training improved their ability to exercise without experiencing shortness of breath, although neither intervention had a significant effect on a measure of quality of life, according to a study in the January 5 issue of JAMA.

6 Jan 2016

Purified cannabinoid reduces seizures in children and young adults with treatment-resistant epilepsy

Children and young adults with severe forms of epilepsy that does not respond to standard antiepileptic drugs have fewer seizures when treated with purified cannabinoid, according to a multi-center study led by researchers from UCSF Benioff Children's Hospital San Francisco.

6 Jan 2016

Millendo signs license agreement, secures funding to test new drugs for treatment of endocrine disorders

Millendo Therapeutics, a University of Michigan startup company, announced an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to test a new compound, MLE4901, for the treatment of polycystic ovary syndrome.

6 Jan 2016

Qualcomm Life expands global connected therapy management collaboration with Novartis

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.

6 Jan 2016

SillaJen reports initiation of multinational randomized Phase 3 study of Pexa-Vec in HCC patients

SillaJen, Inc., a private, clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, has announced the initiation of a multinational randomized Phase 3 open-label study of its lead product candidate, Pexa-Vec (formerly JX-594), in patients with advanced liver cancer, also known as hepatocellular carcinoma (HCC).

5 Jan 2016

Xcovery to present data from X-396 Phase l/ll trial in patients with ALK+ NSCLC at AACR-IASLC conference

Xcovery, a developer of targeted therapeutics for ALK+ non-small cell lung cancer (NSCLC) is scheduled to present January 6th, 2016 at the fourth annual AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic, at the Hard Rock Hotel, in San Diego, CA.

5 Jan 2016

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.

5 Jan 2016

FDA grants Orphan Drug Designation to Ionis Pharmaceuticals' IONIS-HTT Rx for treatment of HD patients

Ionis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to IONIS-HTTRx for the treatment of patients with Huntington's disease (HD).

5 Jan 2016

Medical Condition News

Global action on reducing mercury emissions should lead to billions in economic benefits for U.S.

Easy-to-follow MIND diet helps lower Alzheimer's risk

Genetic mutation in starlings could shed light on mitochondrial disease in humans

Study shows clear role of bacteria in modulating immune function in the lungs

Local health departments could play vital role in tackling mental health issues in U.S.

New research looks at heavy users of mental health care

CAMH researchers identify 428 distinct disease conditions that co-occur in people with FASD

Radiation therapy lowers risk of cancer recurrence in pancreatic cancer surgery patients

Alpha-synuclein protein involved in Parkinson's disease pathology does not behave like a 'prion'

Vision of Britain report shows more than 3 in 10 GPs ‘de-skilled’ in diagnosing eye conditions

Women who earn less than male counterparts more likely to experience depression, anxiety

Study findings question validity of some genetic variations linked with cardiac disorders

Diet or aerobic exercise improves ability to exercise for obese older patients with heart failure

Purified cannabinoid reduces seizures in children and young adults with treatment-resistant epilepsy

Millendo signs license agreement, secures funding to test new drugs for treatment of endocrine disorders

Qualcomm Life expands global connected therapy management collaboration with Novartis

SillaJen reports initiation of multinational randomized Phase 3 study of Pexa-Vec in HCC patients

Xcovery to present data from X-396 Phase l/ll trial in patients with ALK+ NSCLC at AACR-IASLC conference

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

FDA grants Orphan Drug Designation to Ionis Pharmaceuticals' IONIS-HTT Rx for treatment of HD patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News